Drug Pipeline (in pharma context)

A "drug pipeline" is the entire journey a drug takes from the lab bench to the pharmacy shelf. Think of it as a factory assembly line: 1. Discovery → finding compounds that affect the target 2. Lead optimization → refining the best compound 3. Preclinical testing → testing in cells and animals 4. IND filing → asking the FDA for permission to test in humans 5. Phase 1 → safety in humans 6. Phase 2 → efficacy in humans 7. Phase 3 → large-scale confirmation 8. FDA approval → can be sold 9. Phase 4 → post-market monitoring Why "8 in the pipeline" is exciting: Most drug programs start with one compound and hope it works. MUSC has 8 different compounds that each showed promise — so even if one fails (which about 90% of drugs do), they have 7 others ready to go. This is extremely rare and dramatically increases the chance of eventual success.